Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Hofma · SciRah

Researcher profile · Semantic Scholar

S. Hofma

Share profile

S. Hofma — researcher profile on SciRah

h-index: 35
Works: 137
Citations: 13K

Most-cited papers

2018 ESC/EACTS Guidelines on myocardial revascularization.
F. Neumann, M. Sousa-Uva, Anders Ahlsson, F. Alfonso +123 more
2018European Heart Journal4,969 citations Open access
Semantic Scholar
2018 ESC/EACTS Guidelines on myocardial revascularization.
M. Sousa-Uva, F. Neumann, Anders Ahlsson, F. Alfonso +123 more
2018European Journal of Cardio-Thoracic Surgery1,744 citations Open access
Semantic Scholar
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.
P. Smits, S. Hofma, M. Togni, N. Vázquez +9 more
2013The Lancet297 citations
Semantic Scholar
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
M. Gimbel, Khalid Qaderdan, Laura M. Willemsen, R. Hermanides +13 more
2020The Lancet288 citations Open access
Semantic Scholar
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
M. Sabaté, S. Windecker, A. Íñiguez, Lisette Okkels-Jensen +12 more
2015European Heart Journal231 citations Open access
Semantic Scholar
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI
J. Wykrzykowska, R. Kraak, S. Hofma, R. J. van der Schaaf +12 more
2017New England Journal of Medicine229 citations Open access
Semantic Scholar
Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
S. Hofma, J. Brouwer, M. Velders, A. V. van'T Hof +4 more
2012Journal of the American College of Cardiology130 citations Open access
Semantic Scholar
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
S. Garg, P. Serruys, S. Silber, J. Wykrzykowska +19 more
2011JACC: Cardiovascular Interventions118 citations Open access
Semantic Scholar
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.
M. Velders, H. Boden, S. Hofma, S. Osanto +7 more
2013American Journal of Cardiology116 citations
Semantic Scholar
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
G. Vlachojannis, P. Smits, S. Hofma, M. Togni +7 more
2017JACC: Cardiovascular Interventions99 citations Open access
Semantic Scholar
Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.
K. Park, Si-Hyuck Kang, M. Velders, D. Shin +12 more
2013American Heart Journal88 citations
Semantic Scholar
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
R. D. de Winter, Y. Katagiri, T. Asano, Krzysztof P. Milewski +22 more
2017The Lancet79 citations
Semantic Scholar
Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.
M. Velders, H. Boden, A. J. van Boven, B. L. van der Hoeven +6 more
2013American Journal of Cardiology62 citations
Semantic Scholar
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.
G. De Luca, P. Smits, S. Hofma, E. Di Lorenzo +6 more
2017International Journal of Cardiology53 citations
Semantic Scholar
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.
P. Chichareon, R. Modolo, N. Kogame, Kuniaki Takahashi +19 more
2020Atherosclerosis50 citations Open access
Semantic Scholar
Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.
P. Chichareon, R. Modolo, C. Collet, E. Tenekecioğlu +27 more
2019Journal of the American College of Cardiology39 citations Open access
Semantic Scholar
Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention
F. S. van den Brink, T. Meijers, S. Hofma, A. J. van Boven +5 more
2019Netherlands Heart Journal39 citations Open access
Semantic Scholar
Prehospital risk stratification in patients with chest pain
Dennis Sagel, P. Vlaar, R. V. van Roosmalen, I. Waardenburg +19 more
2021Emergency Medicine Journal35 citations Open access
Semantic Scholar
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users
B. Everaert, C. Felix, J. Koolen, P. den Heijer +10 more
2015Netherlands Heart Journal33 citations Open access
Semantic Scholar
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-elu
G. Vlachojannis, P. Smits, S. Hofma, M. Togni +8 more
2015EuroIntervention32 citations
Semantic Scholar
Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals
V. Nijenhuis, P. Stella, J. Baan, B. R. G. Brueren +11 more
2013Netherlands Heart Journal29 citations Open access
Semantic Scholar
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI.
R. Tijssen, R. Kraak, S. Hofma, R. J. van der Schaaf +12 more
2018EuroIntervention27 citations Open access
Semantic Scholar
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial.
S. Hofma, P. Smits, J. Brouwer, M. Velders +4 more
2015EuroIntervention27 citations
Semantic Scholar
Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience.
H. Amrane, F. Porta, A. J. van Boven, P. Boonstra +3 more
2014Interactive Cardiovascular and Thoracic Surgery25 citations
Semantic Scholar
Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation
E. G. Marcos, A. C. da Fonseca, S. Hofma
2011Netherlands Heart Journal25 citations Open access
Semantic Scholar
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II stu
Lorenz Räber, Y. Onuma, S. Brugaletta, H. Garcia-Garcia +11 more
2016EuroIntervention24 citations
Semantic Scholar
Association between angiographic culprit lesion and out-of-hospital cardiac arrest in ST-elevation myocardial infarction patients.
M. Velders, N. van Boven, H. Boden, B. L. van der Hoeven +8 more
2013Resuscitation24 citations
Semantic Scholar
Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent
Kuniaki Takahashi, P. Serruys, N. Kogame, P. Buszman +12 more
2020Circulation. Cardiovascular Interventions23 citations Open access
Semantic Scholar
Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
K. Yamaji, S. Brugaletta, M. Sabaté, A. Íñiguez +11 more
2017JACC: Cardiovascular Interventions23 citations Open access
Semantic Scholar
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.
R. D. de Winter, A. Zaman, H. Hara, Chao Gao +13 more
2022EuroIntervention19 citations Open access
Semantic Scholar
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging.
P. Suwannasom, Y. Onuma, E. Benit, O. Gach +10 more
2016EuroIntervention17 citations Open access
Semantic Scholar
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial.
Chao Gao, N. Kogame, F. Sharif, P. Smits +12 more
2021Circulation. Cardiovascular Interventions16 citations Open access
Semantic Scholar
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease
A. Lansky, D. Kereiakes, A. Baumbach, S. Windecker +22 more
2021Circulation16 citations Open access
Semantic Scholar
Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
H. Hara, P. Serruys, Neil O'Leary, Chao Gao +35 more
2022American Heart Journal15 citations Open access
Semantic Scholar
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.
L. Kerkmeijer, R. Tijssen, S. Hofma, R. J. van der Schaaf +13 more
2019EuroIntervention15 citations Open access
Semantic Scholar
Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial.
L. Kerkmeijer, M. P. L. Renkens, R. Tijssen, S. Hofma +10 more
2021EuroIntervention14 citations Open access
Semantic Scholar
Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
M. Velders, S. Hofma, J. Brouwer, C. D. de Vries +2 more
2013PLoS ONE14 citations Open access
Semantic Scholar
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).
Y. Katagiri, Y. Onuma, T. Asano, A. Íñiguez +10 more
2018EuroIntervention13 citations Open access
Semantic Scholar
Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions
B. Everaert, J. Wykrzykowska, J. Koolen, P. van der Harst +10 more
2017Netherlands Heart Journal12 citations Open access
Semantic Scholar
Bifurcation PCI With a Hybrid Strategy With Drug- Eluting Balloons Versus a Stepwise Provisional Two- Stent Strategy: Rationale and Design of the Hybrid DEB study.
D. Dillen, P. Vlaar, A. J. Vermeer, V. Paradies +15 more
2023American Heart Journal9 citations Open access
Semantic Scholar
Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger
F. S. van den Brink, I. Wijtsma, H. Amrane, T. Vossenberg +4 more
2022Netherlands Heart Journal8 citations Open access
Semantic Scholar
Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial
M. Gimbel, A. Tavenier, W. Bor, R. Hermanides +12 more
2020Journal of Clinical Medicine8 citations Open access
Semantic Scholar
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial
R. Tijssen, L. Kerkmeijer, Y. Katagiri, R. Kraak +21 more
2019The International Journal of Cardiovascular Imaging8 citations Open access
Semantic Scholar
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled Trial
Pieter C. Smits, P. Tonino, S. Hofma, J. van Kuijk +7 more
2024Circulation. Cardiovascular Interventions7 citations Open access
Semantic Scholar
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
D. Claassens, M. Gimbel, T. Bergmeijer, G. J. Vos +21 more
2021International Journal of Cardiology6 citations Open access
Semantic Scholar
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
A. Selvarajah, Annerieke H. Tavenier, W. Bor, V. Houben +10 more
2021European Heart Journal Open5 citations Open access
Semantic Scholar
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
L. Kerkmeijer, R. Tijssen, S. Hofma, T. Pinxterhuis +14 more
2020International Journal of Cardiology5 citations Open access
Semantic Scholar
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy
R. Tijssen, René J. Schaaf, R. Kraak, M. Vink +15 more
2020Catheterization and cardiovascular interventions5 citations
Semantic Scholar
Short-term effects of Nano + TM polymer-free sirolimus-eluting stents on native coronary vessels : an optical coherence tomography imaging study
P. Suwannasom, E. Benit, O. Gach, C. von Birgelen +9 more
20155 citations
Semantic Scholar
Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
M. Velders, A. van Boven, J. Brouwer, P. Smits +4 more
2014Netherlands Heart Journal5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Wykrzykowska×16
Invite
J. Wykrzykowska — researcher profile on SciRah
P. Serruys×15
Invite
P. Serruys — researcher profile on SciRah
Y. Onuma×14
Invite
Y. Onuma — researcher profile on SciRah
P. Smits×12
Invite
P. Smits — researcher profile on SciRah

R. D. de Winter

×12

Invite

R. D. de Winter — researcher profile on SciRah

A. J. van Boven×11

Invite

A. J. van Boven — researcher profile on SciRah

S. Windecker×10

Invite

S. Windecker — researcher profile on SciRah

R. J. van der Schaaf×8

Invite

R. J. van der Schaaf — researcher profile on SciRah

Invite

J. Piek — researcher profile on SciRah

J. Henriques×8

Invite

J. Henriques — researcher profile on SciRah

Invite

M. Velders — researcher profile on SciRah

S. Brugaletta×7

Invite

S. Brugaletta — researcher profile on SciRah